XML 102 R91.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Reporting - Schedule of Information by Segments (Details) - CODM [Member] - USD ($)
 6 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Schedule of Information by Segments [Line Items]    
Cost of revenue $ 10,093,462 $ 7,196,835
Gross profit 3,019,060 480,308
Selling expense 1,093,244  
General and administrative expense 4,318,013  
Depreciation & amortization 145,717 87,132
Income tax provision 81,039 89,581
Capital expenditure   256,314
Long-lived assets 3,089,229 5,399,776
Segment assets 24,300,208 9,837,126
Net Income (Loss) (2,940,897) (3,282,227)
External Customers [Member]    
Schedule of Information by Segments [Line Items]    
Revenue 11,890,794 6,920,149
Related Party [Member]    
Schedule of Information by Segments [Line Items]    
Revenue 1,221,728 756,994
Cross-border freight solutions (U.S.) [Member]    
Schedule of Information by Segments [Line Items]    
Cost of revenue 8,108,196 7,075,044
Gross profit 1,223,672 384,013
Selling expense  
General and administrative expense 2,132,762  
Depreciation & amortization 78,903 86,685
Income tax provision 89,581
Capital expenditure   181,963
Long-lived assets 2,297,112 4,582,950
Segment assets 6,421,111 7,092,574
Net Income (Loss) (1,016,831) (2,129,585)
Cross-border freight solutions (U.S.) [Member] | External Customers [Member]    
Schedule of Information by Segments [Line Items]    
Revenue 8,110,140 6,702,063
Cross-border freight solutions (U.S.) [Member] | Related Party [Member]    
Schedule of Information by Segments [Line Items]    
Revenue 1,221,728 756,994
Pharmaceutical distribution (China) [Member]    
Schedule of Information by Segments [Line Items]    
Cost of revenue 1,985,266 121,791
Gross profit 1,795,388 96,295
Selling expense 1,074,293  
General and administrative expense 356,740  
Depreciation & amortization 23,172 447
Income tax provision 81,039
Capital expenditure   74,351
Long-lived assets 418,551 816,826
Segment assets 3,725,331 1,949,879
Net Income (Loss) 222,675 (334,567)
Pharmaceutical distribution (China) [Member] | External Customers [Member]    
Schedule of Information by Segments [Line Items]    
Revenue 3,780,654 218,086
Pharmaceutical distribution (China) [Member] | Related Party [Member]    
Schedule of Information by Segments [Line Items]    
Revenue
Others [Member]    
Schedule of Information by Segments [Line Items]    
Cost of revenue
Gross profit
Selling expense 18,951  
General and administrative expense 1,828,511  
Depreciation & amortization 43,642
Income tax provision
Capital expenditure  
Long-lived assets 373,566
Segment assets 14,153,766 794,673
Net Income (Loss) (2,146,741) (818,075)
Others [Member] | External Customers [Member]    
Schedule of Information by Segments [Line Items]    
Revenue
Others [Member] | Related Party [Member]    
Schedule of Information by Segments [Line Items]    
Revenue